Hold Alembic Pharmaceuticals, target price Rs 730: JM Financial

JM Financial has hold call on Alembic Pharmaceuticals with a target price of Rs 730. The current market price of Alembic Pharmaceuticals is Rs 586.05. Time period given by analyst is a year when Alembic Pharmaceuticals price can reach defined target.

Alembic Pharmaceuticals, incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 11514.67 Crore) operating in Pharmaceuticals sector.

Alembic Pharmaceuticals key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Royalty Income and Other Operating Revenue for the year ending 31-Mar-2022.


Financials
For the quarter ended 30-09-2022, the company has reported a Consolidated Total Income of Rs 1475.34 Crore, up 16.79 % from last quarter Total Income of Rs 1263.22 Crore and up 13.97 % from last year same quarter Total Income of Rs 1294.52 Crore. Company has reported net profit after tax of Rs 135.00 Crore in latest quarter.

The company’s top management includes Mr.Chirayu Amin, Mr.Pranav Amin, Mr.Shaunak Amin, Mr.R K Baheti, Mr.K G Ramanathan, Mr.Pranav Parikh, Mr.Paresh Saraiya, Dr.Archana Hingorani, Mr.Ashok Barat. Company has K C Mehta & Co. LLP as its auditors. As on 30-09-2022, the company has a total of 20 Crore shares outstanding.

Promoter/FII Holdings
Promoters held 69.61 per cent stake in the company as of September 2022 quarter, while FIIs owned 0 per cent , DIIs 12.51 per cent.